|
Market Closed -
Nasdaq
01:30:00 04/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 151.22 USD | +1.08% |
|
+1.59% | +23.20% |
| 03/09 | AbbVie's blood cancer therapy lowers disease progression, death risk in trial | RE |
| 01/09 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.08% | +1.59% | +15.30% | +17.23% | +23.20% | +33.83% | +97.29% | +110.14% | +96.67% | 19TCr | |
| -0.04% | -1.40% | +3.41% | +7.49% | +7.90% | +57.16% | +108.15% | +346.81% | +1,408.91% | 1,03400Cr | |
| +1.17% | +4.76% | +9.44% | +24.72% | +34.54% | +56.42% | +73.50% | +59.07% | +133.35% | 67TCr | |
| -0.58% | +0.80% | +6.16% | +19.84% | +13.88% | +22.82% | +75.58% | +133.12% | +305.82% | 46TCr | |
| -0.41% | -1.03% | -0.75% | +9.37% | +8.17% | +28.76% | +37.78% | -3.43% | +46.03% | 35TCr | |
| -1.06% | +5.08% | +4.35% | +12.24% | +18.63% | +25.12% | +46.04% | +55.47% | +66.80% | 31TCr | |
| +0.24% | +1.77% | +3.76% | -10.12% | -11.66% | -0.05% | +13.96% | +40.91% | +148.46% | 26TCr | |
| +0.29% | +1.63% | +17.22% | +31.31% | +35.69% | +56.46% | +73.00% | +96.19% | +161.60% | 24TCr | |
| -0.52% | +1.42% | -2.57% | +5.58% | -7.86% | -16.87% | -54.27% | -5.90% | +95.05% | 21TCr | |
| -0.72% | +2.82% | +15.10% | +13.69% | +15.70% | +16.22% | -19.48% | -38.49% | -17.14% | 16TCr | |
| +0.22% | +1.90% | +18.53% | +30.26% | +23.07% | +40.68% | +58.92% | +181.73% | +486.65% | 14TCr | |
| +0.64% | +1.70% | +4.00% | +24.43% | +26.23% | +43.35% | +9.79% | +3.78% | +20.83% | 14TCr | |
| +0.22% | -1.05% | +2.76% | 0.00% | -7.59% | -3.19% | -22.02% | -12.94% | +9.22% | 11TCr | |
| -0.52% | +0.46% | -2.74% | -2.10% | +2.06% | +26.75% | +35.56% | +0.09% | -9.42% | 10TCr | |
| -1.21% | -3.38% | +1.72% | -10.20% | -17.57% | +3.27% | +53.01% | +52.80% | +490.01% | 7.27TCr | |
| -2.62% | -0.81% | +8.83% | +18.62% | +18.99% | +26.69% | +26.91% | +54.36% | +20.96% | 6.06TCr | |
| -0.40% | +0.68% | +1.55% | +37.80% | +32.40% | +71.48% | -3.24% | +2.63% | -48.01% | 5.63TCr | |
| +0.86% | -3.47% | -13.28% | -2.63% | -22.85% | -36.15% | +10.67% | -0.30% | +178.29% | 4.5TCr | |
| -2.32% | -2.66% | +6.27% | +11.54% | +17.33% | +95.20% | +272.15% | +286.29% | -28.50% | 4.27TCr | |
| -0.42% | -3.20% | -0.36% | +8.07% | -4.91% | -2.94% | +12.89% | - | - | 4.26TCr | |
| Average | -0.37% | +0.47% | +4.94% | +12.36% | +10.27% | +27.25% | +45.31% | +71.70% | +187.66% | 23.44TCr | |
| Weighted average by Cap. | -0.32% | +0.92% | +5.82% | +13.40% | +13.82% | +35.56% | +59.12% | +121.87% | +419.20% |
- Stock Market
- Stocks
- GILD Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
